Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction

Nine years elapsed between Gavi’s investment decision to support typhoid conjugate vaccines (TCVs) in 2008 and Gavi support becoming available for countries to introduce TCV. The protracted path toward Gavi support for TCV highlights the challenges of vaccine development for lower-income countries a...

Descripción completa

Detalles Bibliográficos
Autores principales: Soble, Adam, Patel, Zeenat, Sosler, Stephen, Hampton, Lee, Johnson, Hope
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388709/
https://www.ncbi.nlm.nih.gov/pubmed/32725236
http://dx.doi.org/10.1093/cid/ciaa342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388709/
https://www.ncbi.nlm.nih.gov/pubmed/32725236
http://dx.doi.org/10.1093/cid/ciaa342

Ejemplares similares